ATTAIN-1 was a 72-week, randomized, double-blind, placebo-controlled trial comparing the efficacy and safety of orforglipron (6 mg, 12 mg, and 36 mg) as monotherapy vs
Effective exclusivity dates are determined by the Orange Book secondary patent estate, Paragraph IV litigation outcomes, settlement terms, and the deployment of 30-month stays
Ongoing monitoring, adjustments, and support are simplest through our membership, so the program adapts with you over time rather than ending the moment the scale moves
In Turkey, 1 mg of Ozempic costs 7,922 TL ($220), making the monthly treatment $880
Salads without fat look healthy but deliver less